Insider · CIK 0001965071
Markus Puhlmann
Files at CATX (Perspective Therapeutics, Inc.). First filing Dec 19, 2023, latest Dec 19, 2023.
In brief
Markus Puhlmann files SEC Form 4 as officer at CATX (Perspective Therapeutics, Inc.). Since Dec 19, 2023, Markus Puhlmann has reported 1 open-market buy worth $189k and 0 open-market sells worth $0, the latest filed on Dec 19, 2023.
A track record needs three past buys with six months of prices behind them; Markus Puhlmann has 0, so none is measured yet.
The newest scored trade: bought $189k of CATX on Dec 15, 2023, filed Dec 19, 2023, scored 60 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CATX: Perspective Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Perspective Therapeutics, Inc. | $189k 595,425 shares | +119% | +29% from low-63% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Mar 4, 2026 |
| Dec 15, 2023 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +135,006 | $0.27 | $36k | 635,006 | Dec 19, 2023 |
| Dec 18, 2023 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +60,419 | $0.26 | $15k | 695,425 | Dec 19, 2023 |
| Dec 19, 2023 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +400,000 | $0.34 | $137k | 1,095,425 | Dec 19, 2023 |
| Dec 12, 2023 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +1,477,619 | $0.00 | $0 | 2,885,688 | Dec 14, 2023 |
Questions about Markus Puhlmann
Answered from the filings on this page, as of the latest one.
Is Markus Puhlmann buying or selling?
Not in the last 12 months. Markus Puhlmann's latest open-market trade on SEC Form 4 was bought $189k of CATX on Dec 15, 2023.
How did Markus Puhlmann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Markus Puhlmann has 0.
Where does Markus Puhlmann file Form 4?
Markus Puhlmann has filed Form 4 at CATX (Perspective Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.